PharVision Advisers’s La-Z-Boy LZB Stock Holding History

PharVision Advisers’s Portfolio LZB Stock Details LZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,153	Closed	-$304K	–	417
2025 Q4	$304K	Buy	+8,153	New	+$286K	0.15%	261

Other funds holding LZB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PharVision Advisers's LZB Position: Q1 2026 in Review

PharVision Advisers sold out of La-Z-Boy (LZB) in Q1 2026, closing a stake of 8,153 shares — an estimated $304K sold.

PharVision Advisers first reported a position in LZB in Q4 2025 and held it in 1 quarter. The position peaked at $304K in Q4 2025. 263 funds tracked by Wall St. Rank hold LZB as of Q1 2026.

PharVision Advisers reported no remaining La-Z-Boy position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 8,153 La-Z-Boy shares in Q1 2026, an estimated $304K.
PharVision Advisers first reported a position in La-Z-Boy in Q4 2025 and held it in 1 quarter.
PharVision Advisers's La-Z-Boy position peaked at $304K in Q4 2025.
263 funds tracked by Wall St. Rank held La-Z-Boy as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.